BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chuang WL, Liu HW, Chang WY, Chen SC, Hsieh MY, Wang LY. Natural killer cell activity in patients with liver cirrhosis relative to severity of liver damage. Dig Dis Sci. 1991;36:299-302. [PMID: 1995265 DOI: 10.1007/bf01318200] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Himeno H, Enzan H, Saibara T, Onishi S, Yamamoto Y. Immunoelectron microscopic observations on Leu-7 positive cells in virus-related chronic liver diseases. Virchows Arch 1994;424:471-6. [PMID: 7518291 DOI: 10.1007/BF00191431] [Reference Citation Analysis]
2 Riveiro-Barciela M, Buti M, Homs M, Campos-Varela I, Cantarell C, Crespo M, Castells L, Tabernero D, Quer J, Esteban R. Cirrhosis, liver transplantation and HIV infection are risk factors associated with hepatitis E virus infection. PLoS One. 2014;9:e103028. [PMID: 25068388 DOI: 10.1371/journal.pone.0103028] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
3 Feng ZJ, Niu RM, Ren XL, Yao XX. Cellular immune function and liver damage in post-hepatitic cirrhosis. World J Gastroenterol 1997; 3(1): 22-23 [PMID: 27006578 DOI: 10.3748/wjg.v3.i1.22] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Nakamura I. Impairment of innate immune responses in cirrhotic patients and treatment by branched-chain amino acids. World J Gastroenterol 2014; 20(23): 7298-7305 [PMID: 24966600 DOI: 10.3748/wjg.v20.i23.7298] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
5 Hoechst B, Voigtlaender T, Ormandy L, Gamrekelashvili J, Zhao F, Wedemeyer H, Lehner F, Manns MP, Greten TF, Korangy F. Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor. Hepatology. 2009;50:799-807. [PMID: 19551844 DOI: 10.1002/hep.23054] [Cited by in Crossref: 371] [Cited by in F6Publishing: 370] [Article Influence: 28.5] [Reference Citation Analysis]
6 Hwang TL, Chen CY. Gender different response to immunonutrition in liver cirrhosis with sepsis in rats. Nutrients 2012;4:231-42. [PMID: 22666548 DOI: 10.3390/nu4030231] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
7 Hirata M, Harihara Y, Kita Y, Saito S, Nishimuraj M, Yoshino H, Sano K, Ito M, Kusaka K, Kawarasaki H, Hashizume K, Makuuchi M. Immunosuppressive effect of chenodeoxycholic acid on natural killer cell activity in patients with biliary atresia and hepatitis C virus-related liver cirrhosis. Dig Dis Sci 2002;47:1100-6. [PMID: 12018907 DOI: 10.1023/a:1015050410041] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
8 Dollinger MM, Behrens CM, Lesske J, Behl S, Behrmann C, Fleig WE. Thymostimulin in advanced hepatocellular carcinoma: a phase II trial. BMC Cancer 2008;8:72. [PMID: 18366627 DOI: 10.1186/1471-2407-8-72] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
9 Bruns T, Zimmermann HW, Stallmach A. Risk factors and outcome of bacterial infections in cirrhosis. World J Gastroenterol 2014; 20(10): 2542-2554 [PMID: 24627590 DOI: 10.3748/wjg.v20.i10.2542] [Cited by in CrossRef: 72] [Cited by in F6Publishing: 61] [Article Influence: 9.0] [Reference Citation Analysis]